Ensign Group, Inc (ENSG) · Oct 27, 2026 · Earnings
Beat — Adjusted EPS $2.03 vs ~$1.97 consensus
Ensign’s third-quarter earnings narrowly beat consensus, while stronger occupancy and skilled mix drove a higher 2026 earnings outlook.
Ensign is scaling a skilled-nursing and post-acute healthcare platform through acquisitions, while improving the performance of acquired facilities and adding owned healthcare real estate. That strategy was already established before this filing; the new information is that operating momentum is translating into another guidance increase.
The quarter cleared expectations, but the beat was not purely a revenue story. Adjusted EPS was $2.03 versus a published consensus near $1.97, while quarterly revenue of $1.484 billion was below the roughly $1.51 billion estimate. Consensus sources are inconsistent, so the EPS comparison should be treated as directional rather than precise; on the available benchmark, this is a narrow earnings beat. The filing reported, “GAAP diluted earnings per share for the quarter was $1.76, an increase of 23.9% over the prior year quarter, and adjusted diluted earnings per share(2) for the quarter was $2.03, an increase of 23.8% over the prior year quarter.” 〔0〕
| Metric | Q3 2026 | Q3 2025 / expectation |
|---|---|---|
| Total revenue | $1.484B | $1.296B / ~$1.51B consensus |
| GAAP diluted EPS | $1.76 | $1.42 |
| Adjusted diluted EPS | $2.03 | $1.64 / ~$1.97 consensus |
| Net income attributable to Ensign | $104.3M | $83.8M |
| Same-facility occupancy | 84.1% | 82.8% |
| 2026 EPS guidance | $7.94–$8.02 | Prior: $7.75–$7.85 |
The underlying operating trend is stronger than the headline revenue comparison. Same-facility skilled-services revenue rose 5.6%, occupancy increased to 84.1% from 82.8%, and skilled mix by revenue expanded to 51.2% from 49.5% (Same Facility Results). Transitioning facilities also reached 86.1% occupancy and 49.3% skilled mix. The filing said, “Same Facilities and Transitioning Facilities skilled mix revenue for the quarter increased by 10.7% and 10.5%, respectively, over the prior year quarter and skilled days for the quarter increased by 7.2% and 7.9%, respectively, over the prior year quarter.” 〔1〕
The guidance increase is the clearest positive change to the story. Management lifted the 2026 EPS range by $0.17 at both ends, while only raising the lower end of revenue guidance to $5.89 billion and leaving the top at $5.92 billion. That combination implies the upgrade is being driven more by earnings conversion, occupancy, payer mix and operating execution than by a major revenue reset. The company explicitly said, “Due to the strength of the third quarter and our confidence in the fourth quarter, we are increasing our annual 2026 earnings guidance to $7.94 to $8.02 per diluted share, up from our original guidance of $7.75 to $7.85.”
Growth remains acquisition-led, with execution still the key test. Ensign added 22 operations during the quarter and since, including 19 leased operations and three real estate assets; its portfolio now totals 418 healthcare operations across 18 states. Recently acquired facilities grew rapidly, but their 77.4% occupancy and 43.2% skilled mix remain below the same-facility profile, leaving substantial upside but also integration and ramp-up work. The filing said, “During the quarter and since, we accelerated our growth by adding 22 new operations, including three real estate assets and 19 leased operations.” 〔2〕
The real-estate segment is adding support rather than changing the core thesis. Standard Bearer’s rental revenue rose 46.3% to $47.7 million and FFO increased 41.3% to $27.3 million, helped by five newly acquired properties that are now leased to Ensign-affiliated operators. Cash fell to $337.6 million after $690.9 million of nine-month investing outflows, but management reported $731.6 million of available credit capacity, keeping the acquisition engine funded for now (Balance Sheet; Cash Flow statement; Standard Bearer segment results). The filing reported, “Standard Bearer(3) revenue was $47.7 million for the quarter, an increase of 46.3% over the prior year quarter. FFO was $27.3 million for the quarter, an increase of 41.3% over the prior year quarter.”
Bottom line: This is a meaningful step forward for the operating story: a modest EPS beat, stronger same-facility demand and mix, and a raised full-year earnings outlook. Revenue was slightly light versus consensus, but the filing strengthens the case that Ensign is converting its acquisition pipeline into profitable growth rather than merely adding facilities.
Q3 earnings webcast, October 28, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!